Kayoko Mihara Selected Research

Kayoko Mihara Research Topics

Disease

4	Parkinson Disease (Parkinson's Disease) 11/2007 - 06/2004
4	Stroke (Strokes) 03/2007 - 09/2004
4	Thrombosis (Thrombus) 01/2005 - 07/2003
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2007 - 06/2004
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2007 - 03/2004
2	Catalepsy 07/2008 - 11/2007
2	Brain Ischemia (Cerebral Ischemia) 03/2007 - 01/2005
2	Brain Injuries (Brain Injury) 03/2007 - 01/2005
2	Ischemic Stroke 01/2005 - 03/2004
1	Memory Disorders (Memory Loss) 11/2007
1	Cerebral Hemorrhage 11/2005
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2005
1	Hemorrhage 11/2005
1	Intracranial Aneurysm (Cerebral Aneurysm) 11/2005
1	Neurologic Manifestations (Neurological Manifestations) 01/2005
1	Thrombotic Stroke 01/2005
1	Cerebral Infarction 01/2005
1	Brain Infarction 01/2005
1	Carotid Artery Thrombosis 07/2003

Drug/Important Bio-Agent (IBA)

5	((S)- 2- acetylamino- 3- ((R)- (1- (3- (piperidin- 4- yl)propionyl)piperidin- 3- ylcarbonyl))amino) propionic acid trihydrateIBA 11/2005 - 03/2004
2	Adenosine (Adenocard)FDA LinkGeneric 07/2008 - 11/2007
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 07/2008 - 11/2007
2	Haloperidol (Haldol)FDA LinkGeneric 07/2008 - 11/2007
2	5- (5- amino- 3- (4- fluorophenyl)pyrazin- 2- yl)- 1- isopropylprydine- 2(1H)- oneIBA 07/2008 - 11/2007
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 03/2007 - 06/2004
2	Neuroprotective AgentsIBA 09/2004 - 06/2004
1	P-2 (P 2)IBA 11/2007
1	istradefyllineIBA 11/2007
1	Scopolamine (Hyoscine)FDA Link 11/2007
1	Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA 11/2007
1	Dihydroxyphenylalanine (Dopa)IBA 11/2007
1	Dopamine (Intropin)FDA LinkGeneric 11/2007
1	Levodopa (L Dopa)FDA LinkGeneric 11/2007
1	Cytotoxins (Cytolysins)IBA 03/2007
1	PPAR deltaIBA 03/2007
1	GW 501516IBA 03/2007
1	Acetic Acid (Vinegar)FDA LinkGeneric 03/2007
1	4- (3- (2- propyl- 3- hydroxy- 4- acetyl)phenoxy)propyloxyphenoxy acetic acidIBA 03/2007
1	Collagenases (Collagenase)FDA Link 11/2005
1	AnticoagulantsIBA 11/2005
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2005
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2005
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2005
1	Platelet Membrane GlycoproteinsIBA 01/2005
1	Glycoproteins (Glycoprotein)IBA 09/2004
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2004
1	2- (4- chlorophenyl)- 5- quinoxalinecarboxamideIBA 09/2004
1	QuinazolinonesIBA 06/2004
1	Pharmaceutical PreparationsIBA 06/2004
1	2-(3-(4-(4-chlorophenyl)-1-piperazinyl) propyl)-4(3H)-quinazolinoneIBA 06/2004
1	Poly (ADP-Ribose) Polymerase-1IBA 06/2004
1	Thrombin FDA Link 03/2004
1	ThromboxanesIBA 03/2004
1	ozagrelIBA 03/2004
1	argatroban (MPQA)FDA Link 03/2004
1	propionic acid (potassium propionate)IBA 03/2004
1	FR 171113IBA 07/2003
1	PAR-1 ReceptorIBA 07/2003

Therapy/Procedure

1	Intramuscular Injections 07/2008
1	Secondary Prevention 03/2004